Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ·Healthcare·Biotechnology
$4.18
+0.12%
Mkt Cap $327.24M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+67.7%
Consensus $7.00 vs current $4.18
NASDAQ·Healthcare·Biotechnology
$4.18
+0.12%
Mkt Cap $327.24M
Buy
0
Hold
1
Sell
0
Price Target (3 analysts)
$7.00
Range $7.00 – $7.00
+67.7%
Consensus $7.00 vs current $4.18